Bioinformatics in the Post-Genomic Era: Genome, Transcriptome, Proteome, and Information-Based Medicine

During the past decade advanced computing technologies have revolutionizedlife sciences and medical research. The changes are not only dramatic, but theyhave affected virtually everyone in life sciences. Information technology isaccelerating the drug discovery and testing process. Most current books onbioinformatics either lack technical depth, or focus on a specific narrow topic.Jeff Augen's book is the first overview with both broad coverage that doesjustice to the extent of this new field while at the same time having enoughdepth to be of practical use to working professionals. It surveys the mostrecent cutting-edge developments, offering enough technical information to beuseful without overloading the reader or quickly becoming obsolete.

Jeff Augen has a 20-year history in information technology and computational biology. Most recently, as President and CEO of the technical computing software company TurboWorx Inc., Jeff has focused on the design of parallel computing solutions for biomedical research and drug discovery. In his former position as the Director of Strategy for IBM's Life Sciences Division, Jeff was responsible for the company's entry into several new areas of the life sciences computing market including, most notably, information-based medicine. He is a frequent speaker at industry events, a member of several editorial boards, and an author of many recent review articles and editorials, in addition to a chapter on computational biology for Anti-Cancer Drug Development; Lippincott 2003.

Augen's academic background includes graduate and undergraduate degrees in Biochemistry and Molecular Biology from the University of Texas and Rice University, respectively. His thesis research involved the development of algorithms for predicting protein tertiary structure.

© Copyright Pearson Education. All rights reserved.